Literature DB >> 3803380

Susceptibility of Campylobacter species to niridazole.

R M Bannatyne, M A Karmali, J Jackowski, M Roscoe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3803380     DOI： 10.1007/bf02013295

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Vibrio fetus infection in man. I. Ten new cases and some epidemiologic observations.

Authors:  V Bokkenheuser
Journal:  Am J Epidemiol       Date:  1970-04       Impact factor: 4.897

Review 2.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.

Authors:  H Hof; V Sticht-Groh; K M Müller
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

4.  Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.

Authors:  M A Karmali; S De Grandis; P C Fleming
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

5.  Campylobacter laridis causing bacteremia in an immunosuppressed patient.

Authors:  I Nachamkin; C Stowell; D Skalina; A M Jones; R M Hoop; R M Smibert
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

6.  Illness associated with Campylobacter laridis, a newly recognized Campylobacter species.

Authors:  R V Tauxe; C M Patton; P Edmonds; T J Barrett; D J Brenner; P A Blake
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

7.  Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.

Authors:  H Hof; V Sticht-Groh
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

8.  In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole.

Authors:  A M Freydière; Y Gille; S Tigaud; P Vincent
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

9.  Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection.

Authors:  C I Valencia; B A Catto; E H Fairchild; S B Wilson; N C Maramba; L T Webster
Journal:  J Pharmacol Exp Ther       Date:  1984-07       Impact factor: 4.030

10.  Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.

Authors:  H Hof; M Rieffert; V Sticht-Groh; O Zak; E H Schweizer
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191
  10 in total
  1 in total

1.  Susceptibility of Campylobacter species to metronidazole, its bioactive metabolites and tinidazole.

Authors:  R M Bannatyne; J Jackowski; M A Karmali
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.